
Trending Now
1
FDA Approves First Liquid Losartan Formulation
2
Study Shows Widespread Delays in Medical Device Reporting to FDA
3
Passive Heat Therapy Improves Heart Failure Mobility
4
Vutrisiran Receives FDA Nod for ATTR Amyloidosis With Cardiomyopathy
5
Multivitamins After MI: Any Benefit for Patients with Diabetes?
6
Lipid Changes Post-Ivacaftor in Cystic Fibrosis
Conference Coverage
2025 Miami Breast Cancer Conference
AHA EPI | Lifestyle Scientific Sessions 2025
38th Annual Miami Breast Cancer Conference
October 13, 2021
Novel HER2-Targeted Therapies Pose Sequencing Challenges
August 02, 2021
Breast Cancer in 2030: Predictions From a Breast Cancer Luminary
Clinical Guidelines
View More
Commentary & Perspectives
View More
March 17, 2025
How Spaceflight Alters Human Physiology
FDA & Government News
View More

March 18, 2025
Medtronic Recall: FDA Issues Highest-Risk Warning
March 18, 2025
FDA Approves First Liquid Losartan Formulation
Business Management
View More